	US 12,274,680 B2
	Treatment of benign prostatic hypertrophy with capsinoids
George William Creasy, II, Glen Gardner, NJ (US)
Filed by George William Creasy, II, Glen Gardner, NJ (US)
Filed on Mar. 23, 2023, as Appl. No. 18/188,796.
Claims priority of provisional application 63/375,455, filed on Sep. 13, 2022.
Prior Publication US 2024/0082178 A1, Mar. 14, 2024
Int. Cl. A61K 31/165 (2006.01); A61K 9/00 (2006.01); A61K 31/231 (2006.01); A61K 31/357 (2006.01); A61P 13/10 (2006.01)

CPC A61K 31/165 (2013.01) [A61K 9/0053 (2013.01); A61K 31/231 (2013.01); A61K 31/357 (2013.01); A61P 13/10 (2018.01)]

10 Claims

1. A method for reducing bladder outlet obstruction of a male patient with BPH, consisting essentially of:

administering orally to a male patient suffering from a bladder outlet obstruction (BOO) due to a benign prostatic hypertrophy (BPH) a composition consisting of at least one capsaicinoid and/or at least one capsinoid, in an amount equivalent to 20,000-200,000 Scoville Heat Units (SHU), wherein the amount is effective to reduce the bladder outlet obstruction.